J. Molner AS
ISIN: EE3100109034 | Ticker: JML | LEI: 984500F0KEF52E642E45
Country: Estonia
Located in Northern Europe in Estonia, The J. Molner Company's main laboratory was originally founded in 2015 as part of a global pharmaceutical company to accelerate research and development activities. With a focus on sterile injectable and dermatological drugs for both the United States and Canada, our team has developed a GMP certified facility that provides services to pharmaceutical companies looking to grow their pipelines and manage costs by leveraging our capabilities.
Year founded2020
Served areaWorldwide
HeadquartersAkadeemia tee 21/5, 12618 Tallinn – Estonia
EE3100109034
LEI984500F0KEF52E642E45
SectorPharmaceuticals, Biotechnology & Life Sciences
IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.